ArticleJournal of neurosurgery. Case lessons2025
Primary abdominal manifestations of vagus nerve stimulation: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVagus nerve stimulation (VNS) is a neuromodulation option for seizure control in intractable epilepsy. Commonly reported side effects of VNS include manifestations of vagus nerve dysfunction, such as cough, hoarseness, and neck pain. While some patients experience transient nausea and vomiting, more significant gastrointestinal (GI) symptoms have not yet been described in the literature. OBSERVATIONS: The patient is a 13-year-old female with type 4 early infantile epileptic encephalopathy who underwent placement of a left-sided VNS system for treatment of medically refractory epilepsy. After initiation of VNS, she developed abdominal pain, worsened constipation, decreased oral intake progressing to complete oral aversion, and urinary retention. The VNS device was turned off after 6 months, leading to resolution of the listed symptoms. LESSONS: Review of this patient's symptoms highlights two ways that VNS may affect vagal signaling: disruption of pain modulation pathways and aberrant stimulation leading to GI dysmotility. Prior studies of the vagus nerve topography reveal heterogeneity in the layout of fascicles, which are unaccounted for with the current surgical technique. Recognition of the potential association of VNS with this uncommon collection of symptoms is important for surgeons offering this treatment. https://thejns.org/doi/10.3171/CASE25117.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.